Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Health (Holdings) Limited is a Hong Kong-listed investment holding company (HKEX: 2389) that operates a diversified healthcare ecosystem across China. The company focuses on five core business segments: medical and healthcare services, geriatric care, health industrial parks, sports and cultural initiatives, and health industry investments. Through its primary brands, Golden Sun and Hongtai, it provides comprehensive elderly care services including institutional, community, and home-based care. Additionally, the company invests in biotechnology and pharmaceutical funds and develops specialized medical facilities such as rehabilitation hospitals and chronic disease management centers. Beijing Health aims to integrate financial capital with high-quality healthcare resources to become a leading comprehensive industrial investment group in the health sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Health.